| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 2828432-44-4 | (6S,9S,15S,18S)-1-((S)-1-((S)-2-((R)-2-氨基-3-巯基丙酰胺基)-3-羧基丙酰基)吡咯烷-2-基)-9-((S)-仲丁基)-18-(3-胍基丙基)-6-(4-羟基苄基)-15-(羟甲基)-1,4,7,10,13,16-六氧代-2,5,8,11,14,17-六氮杂十九烷-19-酸三氟乙酸盐 | H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH trifluoroacetate | C42H63F3N12O16S | 1081.08 | | |
| 2828432-45-5 | (2S,5S,8S,11S,14S,23S)-23-氨基-14-苄基-2-((S)-仲丁基)-5,8-双(3-胍基丙基)-24-(4-羟基苯基)-11-异丁基-4,7,10,13,16,19,22-七氧代-3,6,9,12,15,18,21-七氮杂二十四烷-1-酸三氟乙酸盐 | DynorphinA(1-8)trifluoroacetate | C48H73F3N14O12 | 1095.18 | | |
| 2828432-46-6 | (4R,7S,10S,13R,16S,19S)-13-((1H-吲哚-3-基)甲基)-19-((S)-2-乙酰氨基-3-(4-硝基苯基)丙酰胺基)-N-((R)-1-氨基-3-(4-羟基苯基)-1-氧代丙烷-2-基)-10-(4-氨基丁基)-16-(4-羟基苄基)-7-((R)-1-羟乙基)-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-羧酰胺三氟乙酸盐 | Cyn154806trifluoroacetate | C58H69F3N12O16S2 | 1311.36 | | |
| 2828432-48-8 | (6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-12,29-双(3-氨基丙基)-6,23-二苄基-9,26-二异丁基-15,32-二异丙基二十四氢二吡咯烷并[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]十氮杂环三十烷-5,8,11,14,17,22,25,28,31,34-十酮三氟乙酸盐 | (6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-12,29-Bis(3-aminopropyl)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyltetracosahydrodipyrrolo[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-5,8,11,14,17,22,25,28,31,34-decaone trifluoroacetat | C62H93F3N12O12 | 1255.47 | | |
| 2828433-07-2 | (R)-2-氨基-5-(((S)-1-羧基-2-(1H-吲哚-3-基)乙基)氨基)-5-氧代戊酸三氟乙酸盐 | (R)-2-Amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid trifluoroacetate | C18H20F3N3O7 | 447.36 | | |
| 2828433-08-3 | (S)-1-((S)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid trifluoroacetate | | C17H26F3N3O6 | 425.41 | | |
| 2828433-09-4 | 3-((1H-Indol-3-yl)methyl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione trifluoroacetate | | C18H18F3N3O4 | 397.348 | | |
| 2828433-10-7 | [SAr9,Met(O2)11]-Substance P 三氟乙酸盐 | [SAr9,Met(O2)11]-Substance P trifluoroacetate | C66H101F3N18O17S | 1507.7 | | |
| 2828433-12-9 | (R)-N-((6R,9S,12S,15S,21S)-12-((1H-吲哚-3-基)甲基)-1-氨基-6-氨基甲酰基-1-亚氨基-15-异丁基- 9,23-二甲基-8,11,14,17,20-五氧代-2,7,10,13,16,19-六氮杂二十一烷-21-基)-2-(2,4-二硝基苯基)吡咯烷-2- 羧酰胺三氟乙酸盐 | Dnp-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-NH2 trifluoroacetate | C47H65F3N14O13 | 1091.1 | | |
| 2828433-13-0 | (S)-6-氨基-2-((S)-6-氨基-2-(2-((S)-1-((3S,6S,9S,12S,15S,18S,21S,24S,30S )-9-(3-胍基丙基)-12-((R)-1-羟乙基)-18-(羟甲基)-3,15,30-三异丁基-21-异丙基-6,24-二甲基-1,4,7,10,13,16,19,22,25,28-十氧代-1-((S)-吡咯烷-2-基)-2,5,8,11,14,17,20,23,26,29-十氮杂三十烷-31-酰基)吡咯烷-2-甲酰胺基)乙酰胺基)六氨基)己酸三氟乙酸盐 | L-Prolyl-L-leucyl-L-alanyl-L-arginyl-L-threonyl-L-leucyl-L-seryl-L-valyl-L-alanylglycyl-L-leucyl-L-prolylglycyl-L-lysyl-L-lysine trifluoroacetate | C70H123F3N20O20 | 1621.84 | | |
| 2828433-14-1 | SN50三氟乙酸盐 | SN50 trifluoroacetate | C131H231F3N36O31S | 2895.5187 | | |
| 2828433-15-2 | (S)-1-((S)-2-((S)-2-(2-((S)-1-((S)-1-((S)-2-氨基-5-胍基戊酰基))吡咯烷-2-羰基)吡咯烷-2-甲酰胺基)乙酰胺基)-3-苯基丙酰胺基)-3-羟基丙酰基)吡咯烷-2-羧酸三氟乙酸盐 | H-Arg-Pro-PRO-Gly-Phe-Ser-Pro-OH trifluoroacetate | C37H53F3N10O11 | 870.87 | | |
| 2828433-16-3 | (S)-5-(((S)-1-氨基-3-羟基-1-氧代丙烷-2-基)氨基)-4-((S)-1-((3S,6S,9S,15S,18S,21S)-1-((S)-1-((S)-2-((S)-2-((R)-2-((S)-2-氨基-3-羟基丙胺基)-3-巯基丙胺基)-3-羟基丙胺基)-4-甲基戊酰基)吡咯烷-2-基)-3,18-双(3-氨基-3-氧代丙基)-21-(4-氨基丁基)-6-((R)-1-羟乙基)-9-(羟甲基)-15-丁基-1,4,7,10,13,16,19-七氧代-2,5,8,11,14,17,20-七 | H-Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser-NH2 trifluoroacetate | C66H110F3N19O26S | 1674.75 | | |
| 2828433-17-4 | (S)-6-氨基-N-((S)-1-氨基-4-甲基-1-氧代戊-2-基)-2-((S)-2-((S)-2-氨基- 4-甲基戊酰胺)-3-羟基丙酰胺)己酰胺三氟乙酸盐 | LSKL, INhibitor of Thrombospondin (TSP-1) trifluoroacetate | C23H43F3N6O7 | 572.62 | | |
| 2828433-18-5 | (S)-2-((S)-1-((S)-6-氨基-2-((2S,3R)-2-氨基-3-羟基丁酰胺基)己酰基)吡咯烷-2-甲酰胺基)-5-胍基戊酸三氟乙酸盐 | Tuftsin trifluoroacetate | C23H41F3N8O8 | 614.62 | | |
| 2828433-19-6 | (5S,8S,14S,17S,20S,23S)-23-((2S,3R)-2-((S)-6-氨基-2-((S)-2-氨基-3-(1H-咪唑-4-基)丙胺基)己胺基)-3-羟基丁胺基)-17-苄基-5-氨基甲酰基-20-(羟甲基)-8-异丁基-14-异丙基-7,10,13,16,19,22-六氧代-2-硫杂-6,9,12,15,18,21-六氮杂二十五烷-25-酸三氟乙酸盐 | Neurokinin A trifluoroacetate | C52H81F3N14O16S | 1247.34 | | |
| 2828433-22-1 | (S)-2-((S)-5-氨基-2-((S)-5-氨基-2-((S)-1-((S)-6-氨基-2-((S)-1-((S)-2-氨基-5-胍基戊酰基)吡咯烷-2-羧酰胺基)己酰基)吡咯烷-2-羧酰胺基)-5-氧代戊酰氨基)-5-氧代戊酰氨基)-3-苯基丙酸三氟乙酸盐 | 1-7-Substance P trifluoroacetate | C43H66F3N13O12 | 1014.08 | | |
| 2828433-23-2 | (6S,12S,15S)-1-氨基-6-(2-氨基乙酰氨基)-12-(羧甲基)-15-(羟甲基)-1-亚氨基-7,10,13-三氧代-2,8,11,14-四氮杂十六烷-16-酸三氟乙酸盐 | Gly-Arg-Gly-Asp-Ser TFA | C19H31F3N8O11 | 604.49 | | |
| 2828433-24-3 | 4-氨基-1-((R)-6-氨基-2-((R)-2-((R)-2-((R)-2-氨基-3-苯基丙酰胺基)-3-苯基丙酰胺基)- 4-甲基戊胺基)己酰基)哌啶-4-羧酸三氟乙酸盐 | 4-Amino-1-((R)-6-amino-2-((R)-2-((R)-2-((R)-2-amino-3-phenylpropanamido)-3-phenylpropanamido)-4-methylpentanamido)hexanoyl)piperidine-4-carboxylic acid trifluoroacetate | C38H54F3N7O8 | 793.87 | | |
| 2828433-25-4 | KL4 (peptide)三氟乙酸盐 | KL4 (peptide) trifluoroacetate | C128H239F3N26O24 | 2583.42 | | |
| 2828433-26-5 | Sar-Arg-Val-Tyr-Ile-His-Pro-Ala TFA salt | | C45H68F3N13O12 | 1040.1 | | |
| 2828433-27-6 | (S)-2-((S)-3-(1H-咪唑-5-基)-2-(5-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)戊酰胺基)乙酰胺基)丙胺基)-6-氨基己酸三氟乙酸盐 | Biotinoyl-Tripeptide-1 trifluoroacetate | C26H39F3N8O8S | 680.7 | | |
| 2828433-28-7 | (2S,3R)-2-((S)-6-氨基-2-棕榈酰氨基己酰胺)-3-羟基丁酸三氟乙酸盐 | N2-(1-Oxohexadecyl)-L-lysyl-L-threonine trifluoroacetate | C28H52F3N3O7 | 599.72 | | |
| 2828433-29-8 | PHI 27 (human)三氟乙酸盐 | PHI 27 (human) trifluoroacetate | C137H215F3N34O42S | 3099.4358 | | |
| 2828433-30-1 | Lactoferrin醋酸盐 | Lactoferrinacetate | C143H228N46O31S3 | 3183.83 | | |
| 2828433-31-2 | (3S,5S,7S)-N-((S)-1-(((S)-1-氨基-1-氧代-3-苯基丙烷-2-基)氨基)-5-胍基-1-氧代戊烷-2-基)金刚烷-1-甲酰胺醋酸盐 | RF9 acetate | C28H42N6O5 | 542.67 | | |
| 2828433-32-3 | (S)-1-((S)-2-氨基-3-(4-羟基苯基)丙酰基)吡咯烷-2-羧酸醋酸盐 | Tyr-pro acetate | C16H22N2O6 | 338.36 | | |
| 2828433-33-4 | (S)-1-(2-((S)-1-((5S,8S,11S,14S)-11-((1H-咪唑-4-基)甲基)-5-氨基-14-苄基- 8-(2-羧乙基)-6,9,12-三氧代-2-硫杂-7,10,13-三氮杂十五烷-15-酰基)吡咯烷-2-羧酰胺基)乙酰基]吡咯烷-2-羧酸醋酸盐 | L-Methionyl-L-glutamyl-L-histidyl-L-phenylalanyl-L-prolylglycyl-L-proline acetate | C39H55N9O12S | 873.97 | | |
| 2828433-34-5 | (S)-2-((S)-1-((S)-2,6-二氨基己酰基)吡咯烷-2-羧酰胺基)-3-甲基丁酸醋酸盐 | L-lysyl-L-prolyl-L-valine acetate | C18H34N4O6 | 402.49 | | |
| 2828433-35-6 | (6S,9S,12S,15S,18S,21S,24S,27S,30S)-27-((1H-吲哚-3-基)甲基)-1-氨基-6-((S)-2-氨基-3-(4-羟基苯基)丙酰胺基)-15-(4-氨基丁基)-12-(3-胍基丙基)-18,30-双(4-羟基苄基)-9,21,24-三(羟甲基)-1-亚氨基7,10,13,16,19,22,25,28-八氧代-2,8,11,14,17,20,23,26,29-九氮杂三十烷-31-酸三氟乙酸盐 | L-Tyrosyl-L-arginyl-L-seryl-L-arginyl-L-lysyl-L-tyrosyl-L-seryl-L-seryl-L-tryptophyl-L-tyrosine acetate | C67H94N18O19 | 1455.57 | | |
| 2828433-36-7 | (S)-N-((6S,9R,12S,15S)-12-((1H-咪唑-5-基)甲基)-1-氨基-6-((S)-1-氨基-3-(1H-吲哚-3-基)-1-氧代丙烷-2-基)氨甲酰基)-9-苄基-1-亚氨基-8,11,14-三氧代-2,7,10,13-四氮杂十六烷-15-基)-2-乙酰胺乙酸盐 | Melitane (Acetyl Hexapeptide-1) acetate | C45H63N13O9 | 930.063 | | |
| 2828433-37-8 | (S)-N-((S)-1-氨基-3-羟基-1-氧代丙烷-2-基)-1-((2S,8S,11R,14S)-14-氨基-8-苄基-2 -(4-羟基苄基)-15-(4-羟基苯基)-11-甲基-4,7,10,13-四氧代-3,6,9,12-四氮杂十五烷-1-基)吡咯烷-2-羧酰胺三氟乙酸盐 | | C42H54N8O12 | 862.92 | | |
| 2828433-38-9 | (2S,5S,8S,11S,14S,17S,20S,23S,26S)-14-((1H-吲哚-3-基)甲基)-26-((S)-5-氨基-2-(( S)-2-氨基丙酰胺基)-5-氧代戊酰胺基)-5-(2-氨基-2-氧代乙基)-17-(3-氨基-3-氧代丙基)-23-苄基-2-((R)-1- 羟乙基)-11-异丁基-20-异丙基-8-(2-(甲硫基)乙基)-4,7,10,13,16,19,22,25-八氧代-3,6,9,12,15,18,21,24-八氮杂二十八烷-1,28-二酸 铵盐 | H-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH ammonium salt | C61H92N16O18S | 1369.54 | | |
| 2828433-39-0 | 顺式-5-(4-(三氟甲基)苯基)四氢呋喃-2-羧酸甲酯 | cis-Methyl 5-(4-(trifluoromethyl)phenyl)tetrahydrofuran-2-carboxylate | C13H13F3O3 | 274.24 | | 312.2±42.0 °C(Predicted) |
| 2828433-41-4 | (3S,7S,14R,23S,27S)-5,13,17,25-四氧代-14-(2-氧代-1-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)-6,9,12,15-四氧杂-3-氮杂十八酰胺基)-4,6,12,18,24,26-六氮杂二十九烷-1,3,7,23,27,29-六羧酸 | (3S,7S,14R,23S,27S)-5,13,17,25-Tetraoxo-14-(2-oxo-1-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-6,9,12,15-tetraoxa-3-azaoctadecanamido)-4,6,12,18,24,26-hexaazanonacosane-1,3,7,23,27,29-hexacarboxylic acid | C56H94N12O28 | 1383.41 | | |
| 2828433-43-6 | (2,3-二氯-5-氟苯基)硼酸 | (2,3-Dichloro-5-fluorophenyl)boronic acid | C6H4BCl2FO2 | 208.81 | | |
| 2828433-44-7 | (S)-2-(2-(甲硫基)苯基)吡咯烷盐酸盐 | (S)-2-(2-(Methylthio)phenyl)pyrrolidine hydrochloride | C11H16ClNS | 229.769 | | |
| 2828433-45-8 | 顺式-3,4-二氨基吡咯烷-1-羧酸叔丁酯二盐酸盐 | cis-tert-Butyl 3,4-diaminopyrrolidine-1-carboxylate dihydrochloride | C9H21Cl2N3O2 | 274.19 | | |
| 2828433-46-9 | (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-(叔丁基)-4,5-二氢噁唑) | (4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) | C19H34N2O2 | 322.49 | | |
| 2828433-47-0 | (4R,4'R)-2,2'-(1,3-二(喹啉-2-基)丙烷-2,2-二基)双(4-苄基-4,5-二氢恶唑) | (4R,4'R)-2,2'-(1,3-Di(quinolin-2-yl)propane-2,2-diyl)bis(4-benzyl-4,5-dihydrooxazole) | C41H36N4O2 | 616.75 | | 773.9±60.0 °C(Predicted) |
| 2828433-48-1 | (E)-3-(4-溴苯基)丙-2-烯-1-胺盐酸盐 | (E)-3-(4-Bromophenyl)prop-2-en-1-amine hydrochloride | C9H11BrClN | 248.55 | | |
| 2828433-50-5 | 4-(3-溴-1-异丙基-1H-吲哚-5-基)哌嗪-1-羧酸叔丁酯 | tert-Butyl 4-(3-bromo-1-isopropyl-1H-indol-5-yl)piperazine-1-carboxylate | C20H28BrN3O2 | 422.37 | | 520.6±50.0 °C(Predicted) |
| 2828433-52-7 | (R)-4-异丙基-2-(吡啶-2-基甲基)-4,5-二氢恶唑 | (R)-4-Isopropyl-2-(pyridin-2-ylmethyl)-4,5-dihydrooxazole | C12H16N2O | 204.27 | | |
| 2828433-53-8 | (3aR,8aS)-2-(吡啶-2-基甲基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 | (3aR,8aS)-2-(Pyridin-2-ylmethyl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole | C16H14N2O | 250.3 | | |
| 2828433-54-9 | 3-氨基-4-苯基丁酸氢碘酸盐 | 3-Amino-4-phenylbutanoic acid hydroiodide | C10H14INO2 | 207.13 | | |
| 2828433-55-0 | 1,3-双((3aR,8aS)-8,8a-二氢-3aH-茚并[1,2-d]恶唑-2-基)苯 | 1,3-Bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)benzene | C26H20N2O2 | 392.45 | | 611.6±55.0 °C(Predicted) |
| 2828433-56-1 | Ser-Leu-Pro-Ser-Ala-Glu-Asp-Gln-Ala-Ser-Pro-Ser-Gly-Val-Val-DOTA | | C76H124N20O32 | 1829.91 | | |
| 2828433-57-2 | 钌(1+), 双(2,2'-联吡啶-κN1,κN1')([2,2'-联吡啶]-4-羧基-κN1,κN1')-, 氯化氢(1:1:2) | Ruthenium(1+), bis(2,2'-bipyridine-κN1,κN1')([2,2'-bipyridine]-4-carboxylato-κN1,κN1')-, hydrogen chloride (1:1:2) | C31H24Cl2N6O2Ru | 684.54 | | |
| 2828433-59-4 | (Ir[甲基(甲基)ppy]2(5,5'-dCF3bpy))PF6 | (Ir[Me(Me)ppy]2(5,5'-dCF3bpy))PF6 | C38H30F12IrN4P | 993.84 | | |
| 2828433-60-7 | rel-(3aS,6aR)-5-(叔丁氧基羰基)六氢-3aH-呋喃并[2,3-c]吡咯-3a-羧酸 | rel-(3aS,6aR)-5-(tert-Butoxycarbonyl)hexahydro-3aH-furo[2,3-c]pyrrole-3a-carboxylic acid | C12H19NO5 | 257.28 | | 393.9±37.0 °C(Predicted) |